Diabetes Solutions Landscape, US Phase 2, Part 4

Part
01
of one
Part
01

Diabetes Solutions Landscape KPI - Blue Star

BlueStar, a comprehensive diabetes health app is a diabetes management system to help people with type 2 diabetes. As mentioned on the WellDoc's website, BlueStar causes "a mean reduction of 1.7 to 2.0 point A1C drop for individuals living with type 2 diabetes".

As requested, a more comprehensive look into the apps Key Performance Indicators (KPI) has been detailed in row 21, columns T-AO of the attached spreadsheet.

FINDINGS

BlueStar was developed by WellDoc as a consumer diabetes health app. The app provides "real-time and timely individualized coaching and support, as well as diabetes educational tools that are actionable and personalized for each individual".

According to an article, WellDoc is the "first digital health company" which organizes randomized clinical trials to signify the clinical outcomes. For BlueStar too, the company conducted clinical trials. The app has been approved by FDA as a Class II medical device. It is available only in English and received high user satisfaction.

WellDoc raised $7.5 millions in the most recent venture funding round, Series B. According to a press release (January 2018), Solera Health is partnering with WellDoc for its digital therapeutic app, BlueStar "as a diabetes management solution of choice".

BlueStar is also the first diabetes health app "to be eligible for reimbursement".

CONCLUSION

To wrap it up, KPIs for diabetes solution BlueStar, such as number of users, ratings, consumer satisfaction, and funding, have been entered in row 21, columns T-AO of the attached spreadsheet.

Sources
Sources